Introduction: The data on comparison of costs and benefits for aortic valve replacement from an Australian healthcare perspective are scarce. The study quantifies hospital-associated resource use and costs of trans-catheter valve insertion (TAVI) and surgical aortic valve replacement (SAVR) procedures including length of stay, ICU hours; subsequent hospital admissions related to aortic stenosis, over 12 months.
Methods: A retrospective cohort analysis of patients who underwent TAVI or SAVR undertaken at Royal Prince Alfred Hospital (2012–2017). Patients were identified using the hospital patient database and electronic medical records. Resource use was valued using the Independent Hospital Pricing Authority’s net efficient price and national weighted activity units (NWAUs). Results are presented as mean values with standard deviations, and costs are presented in 2017 Australian dollars.
Results: Of 482 patients, mean age 77 years (SD 13), 64% males.
